ZEISSLER, Marie-Louise. Δ9–TETRAHYDROCANNABINOL IS PROTECTIVE THROUGH PPARγ DEPENDENT MITOCHONDRIAL BIOGENESIS IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE. Journal of Neurology, Neurosurgery, Psychiatry. Roč. 2013, čís. 84. Dostupné online. DOI10.1136/jnnp-2013-306573.150. ((anglicky))
cancer.gov
Cannabis and Cannabinoids. National Cancer Institute [online]. Rev. 30.10.2013. Dostupné online. ((anglicky))
doi.org
dx.doi.org
MECHOULAM, Raphael. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish. Journal of the American Chemical Society. Roč. 1964, čís. 86, s. 1646–164. DOI10.1021/ja01062a046. ((anglicky))
BURNS, Tammy L.; INECK, Joseph R. Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain. Annals of Pharmacotherapy. Roč. 2006, čís. 40, s. 251–260. DOI10.1345/aph.1G217. PMID16449552. ((anglicky))
HANEY, M.; GUNDERSON, E. W.; RABKIN, J. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.. Journal of Acquired Immune Deficiency Syndromes. 15.08.2007, roč. 2007, čís. 45, s. 545–554. DOI10.1097/QAI.0b013e31811ed205. PMID17589370. ((anglicky))
ZEISSLER, Marie-Louise. Δ9–TETRAHYDROCANNABINOL IS PROTECTIVE THROUGH PPARγ DEPENDENT MITOCHONDRIAL BIOGENESIS IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE. Journal of Neurology, Neurosurgery, Psychiatry. Roč. 2013, čís. 84. Dostupné online. DOI10.1136/jnnp-2013-306573.150. ((anglicky))
CARTER, Gregory T.; ABOOD, Mary E. Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials. American Journal of Hospice & Palliative Medicine. Roč. 2010, čís. 27, s. 347–356. DOI10.1177/1049909110369531. ((anglicky))
NOVOTNÁ, A; MAREŠ, J. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.. European Journal of Neurology. Roč. 2011, čís. 18, s. 1122–1131. DOI10.1111/j.1468-1331.2010.03328.x. ((anglicky))
GUZMÁN, M. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.. British Journal of Cancer. Roč. 2006, čís. 95, s. 197–203. DOI10.1038/sj.bjc.6603236. PMID16804518. ((anglicky))
SALAZAR, M. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. The Journal of Clinical Investigation. Roč. 2009, čís. 119, s. 1359–1372. Dostupné online. DOI10.1172/JCI37948. ((anglicky))
SALAZAR, M. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. The Journal of Clinical Investigation. Roč. 2009, čís. 119, s. 1359–1372. Dostupné online. DOI10.1172/JCI37948. ((anglicky))
jneurosci.org
VAN DER STELT, M. Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity. The Journal of Neuroscience. Roč. 2001, čís. 21, s. 6475–9. Dostupné online. PMID11517236. ((anglicky))
nih.gov
ncbi.nlm.nih.gov
BURNS, Tammy L.; INECK, Joseph R. Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain. Annals of Pharmacotherapy. Roč. 2006, čís. 40, s. 251–260. DOI10.1345/aph.1G217. PMID16449552. ((anglicky))
HANEY, M.; GUNDERSON, E. W.; RABKIN, J. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.. Journal of Acquired Immune Deficiency Syndromes. 15.08.2007, roč. 2007, čís. 45, s. 545–554. DOI10.1097/QAI.0b013e31811ed205. PMID17589370. ((anglicky))
VAN DER STELT, M. Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity. The Journal of Neuroscience. Roč. 2001, čís. 21, s. 6475–9. Dostupné online. PMID11517236. ((anglicky))
MÜLLER-VAHL, K.R. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.. The Journal of clinical psychiatry. Roč. 2003, čís. 64, s. 459–465. PMID12716250. ((anglicky))
GUZMÁN, M. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.. British Journal of Cancer. Roč. 2006, čís. 95, s. 197–203. DOI10.1038/sj.bjc.6603236. PMID16804518. ((anglicky))